Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of Apremilast in patients with Erythema Nodosum Leprosum has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Nodosum Leprosum

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Erythema Nodosum Leprosum | Phase 4 | Status: COMPLETED